Indian science administrator
Balram Bhargava ▸ Facts ▸ Comments ▸ News ▸ Videos
‘No difference in Covid death percentage between first & second wave’: ICMR D-G
Credit: HT Digital Content Duration: 01:57Published
No difference in death percentage between 1st and 2nd COVID wave: ICMR DG
Credit: ANI Duration: 01:03Published
Covid: Centre explains 5 steps discussed with States to curb virus spread
Credit: HT Digital Content Duration: 09:52Published
You Might Like
Only 2-4 infections per 10k found in those vaccinated with two doses: ICMRIn a strong validation of the utility of vaccines in combating Covid 19, the Indian Council of Medical Research (ICMR) on Wednesday said only 2-4 per 10,000 “breakthrough” infections were noted in..
Covid-19 vaccines are disease-modifying, reduce chances of severe infection, mortality: ICMR chiefCovid-19 vaccines reduce the chances of developing severe infection and mortality, ICMR chief Balram Bhargava said on Tuesday.
Covishield, Covaxin effective against UK, Brazillian variants; work against South African strain on: GovtBoth Covishield and Covaxin vaccines are effective against the UK and the Brazillian variants of coronavirus, while the work against the South African strain was on at several laboratories, the Centre..
South Africa, Brazil mutated Covid strains have reached IndiaThe South African and Brazilian mutant strains of coronavirus have entered the country, apart from the UK variant reported in 187 people so far. Four persons were detected with the South Africa variant..
Those on blood thinners can receive vaccine, says ICMRFact-sheets of both Covaxin and Covishield will be revised soon so that people on blood thinners like aspirin and clopidogrel can receive the vaccines, while those on anticoagulants may also take the..
No irregularity in approval to Covaxin: ICMRIn an urgent situation like the Covid pandemic, the drug regulator has the authority to give approval for restricted use to a vaccine based on its safety and immunogenicity data from phase 1 and 2..
Emergency use of vaccine is based on safety, immunogenicity data, says ICMR chiefThe Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and..
ICMR chief Balram Bhargava admitted to AIIMS after testing positive for COVID-19This comes as India's COVID-19 caseload rose to 99.79 lakh with 22,890 new infections being reported in a day.
ICMR chief Balram Bhargava undergoing treatment for Covid-19 at AIIMS Trauma CentreIndian Council of Medical Research (ICMR) Director General Balram Bhargava is undergoing treatment for Covid-19 at the AIIMS Trauma Centre here, official sources said on Friday. Bhargava, who is also a..
‘Adverse event’ won’t affect vaccine rollout plan: GovernmentICMR director general Dr Balram Bhargava said adverse events occur with drugs, vaccines or any other health interventions. It is the role of the regulator after collating all the data to ascertain or..
‘No vaccine for respiratory diseases has 100% efficacy’No vaccine for respiratory diseases has a 100% efficacy and ones with a 50-100% efficacy may be approved for use against the Covid-19 pandemic, Indian Council for Medical Research (ICMR) director..
Govt asks states to upload rapid antigen testing data on ICMR portalIn a letter to all states and union territories Indian Council for Medical Research director general Balram Bhargava has said that with the use of rapid antigen tests, more and more tests are being..
Two indigenous Indian vaccines cleared to start human trials, each has 1,000 volunteersIndia is perceived and is an important player in the global vaccine supply, fast-tracking COVID-19 vaccine development is a moral duty, ICMR chief Balram Bhargava said.
No vaccine before 2021, science minister says in release, deletes itA fresh controversy erupted over India’s Covid-19 vaccine timelines with a department of science and technology (DST) press release first mentioning and then deleting a reference to the antidote..
India is not in community transmission: ICMRThere is no community transmission of Covid-19 in the country according to the Indian Council of Medical Research (ICMR) on Thursday. Professor (Dr) Balram Bhargava, DG, ICMR, at a press conference in..
'No harm, potential benefits': ICMR continues recommendation on use of hydroxychloroquine for preventive treatmentResponding to a query on the efficacy of hydroxychloroquine during a media briefing on COVID-19, ICMR chief Balram Bhargava said biological plausibility of HCQ was supporting that it might be an..
Centre asks states to set up exclusive facilities for treating covid-19 patientsAddressing reporters on the preparedness of the government for prevention and containment of the disease, health ministry officials said the country has the capacity for conducting around 60,000-70,000..
72 functional labs for coronavirus testing, private players to be engaged soon: ICMRPrivate NABL-accredited labs will soon be operationalised across the country, ICMR chief Balram Bhargava said.